These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14963475)

  • 41. Blood gas changes in the corpora cavernosa: metabolic and histomorphometric implications in the patient with erectile dysfunction.
    Sasso F; Falabella R; Gentile G; Servello C; Gulino G
    J Urol; 2003 Jun; 169(6):2270-4. PubMed ID: 12771768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.
    Kadioğlu A; Memişoğlu K; Sazoya O; Tüzün E
    Arch Esp Urol; 1998 Sep; 51(7):739-40. PubMed ID: 9807905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1.
    Pilatz A; Schultheiss D; Gabouev AI; Schlote N; Mertsching H; Jonas U; Stief CG
    BJU Int; 2005 Jun; 95(9):1351-7. PubMed ID: 15892829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflex penile erection in anesthetized mice: an exploratory study.
    Allard J; Edmunds NJ
    Neuroscience; 2008 Jul; 155(1):283-90. PubMed ID: 18599219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration.
    Sezen SF; Burnett AL
    J Androl; 2000; 21(2):311-5. PubMed ID: 10714826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prostaglandin E1--the pharmacologic prosthesis].
    de Boccard GA; Rochat CH
    Ann Urol (Paris); 1993; 27(3):152-5. PubMed ID: 8352576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracavernosal kinetics of eicosanoids and endothelin during erection. Data from human and animal studies on intrapenile and systemic prostaglandins.
    Köhler H; Sohn M; Klein CL; Sikora R; Bosshardt R; Jakse G; Kirkpatrick CJ
    Int J Impot Res; 1993 Mar; 5(1):3-12. PubMed ID: 8348210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
    Sahin M; Başar MM; Bozdoğan O; Atan A
    Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erectile dysfunction: anatomical parameters, etiology, diagnosis, and therapy.
    Hafez ES; Hafez SD
    Arch Androl; 2005; 51(1):15-31. PubMed ID: 15764414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective role of the glans penis during coitus.
    Hatzichristou DG; Tzortzis V; Hatzimouratidis K; Apostolidis A; Moysidis K; Panteliou S
    Int J Impot Res; 2003 Oct; 15(5):337-42. PubMed ID: 14562134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of the current status of topical treatments for premature ejaculation.
    Morales A; Barada J; Wyllie MG
    BJU Int; 2007 Sep; 100(3):493-501. PubMed ID: 17608824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral modulation of dopaminergic receptors affects erectile responses in rats.
    El-Din MM; Senbel AM; Daabees TT; Sharabi FM
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):225-32. PubMed ID: 17371526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketanserin plus prostaglandin E1 (PGE-1) as intracavernosal therapy for patients with erectile dysfunction unresponsive to PGE-1 alone.
    Mirone V; Imbimbo C; Fabrizio F; Longo N; Palmieri A
    Br J Urol; 1996 May; 77(5):736-9. PubMed ID: 8689122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral terbutaline in the management of pharmacologically induced prolonged erection.
    Priyadarshi S
    Int J Impot Res; 2004 Oct; 16(5):424-6. PubMed ID: 14999218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial.
    Cai T; Palumbo F; Liguori G; Mondaini N; Scroppo FI; Di Trapani D; Cocci A; Zucchi A; Verze P; Salonia A; Palmieri A
    Int J Impot Res; 2019 Mar; 31(2):119-125. PubMed ID: 30323234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracavernosal pressure characteristics analyzed by power spectral density for identifying the phase of penile erection.
    Han WR; Chuang CY; Li PC; Chen KK; Young ST
    Int J Impot Res; 2009; 21(6):336-42. PubMed ID: 19587686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracavernosal adrenalin injection in priapism.
    Keskin D; Cal C; Delibaş M; Ozyurt C; Günaydin G; Nazli O; Cüreklibatir I
    Int J Impot Res; 2000 Dec; 12(6):312-4. PubMed ID: 11416834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accurate and time-saving, two-step intracavernosal injection procedure to diagnose psychological erectile dysfunction.
    Santi D; Spaggiari G; Simoni M; Granata ARM
    Andrology; 2022 Jul; 10(5):852-862. PubMed ID: 35279959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 60. Transcutaneous minoxidil in the treatment of erectile dysfunctions in spinal cord injured men.
    Beretta G; Saltarelli O; Marzotto M; Zanollo A; Re B
    Acta Eur Fertil; 1993; 24(1):27-30. PubMed ID: 8303971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.